John Yongbo Li, MD, MBA
About John Yongbo Li, MD, MBA
John Yongbo Li, MD, MBA, serves as the Senior Medical Director of Safety at Arcus Biosciences, where he focuses on developing benefit-risk strategies for oncology assets. With extensive experience in drug safety and clinical trials, he has held key positions at various pharmaceutical companies, including ICON plc, Wyeth, Novartis, and CSL Behring.
Current Role at Arcus Biosciences
John Yongbo Li serves as the Senior Medical Director of Safety at Arcus Biosciences, a position he has held since 2022. In this role, he provides leadership in developing benefit-risk strategies specifically for oncology assets. His responsibilities include overseeing core medical activities related to risk management within the oncology portfolio. Arcus Biosciences is located in Hayward, California, and focuses on innovative cancer therapies.
Previous Experience at ICON plc
Before joining Arcus Biosciences, John Yongbo Li worked at ICON plc from 2010 to 2018. He held various positions, including Drug Safety Physician, Senior Drug Safety Physician, and US Team Leader. His tenure at ICON plc spanned eight years, during which he contributed to drug safety and pharmacovigilance efforts.
Education and Expertise
John Yongbo Li holds a Doctor of Medicine (MD) degree from Hebei Medical University and a Master of Business Administration (MBA) from the University of Phoenix. Additionally, he completed a Post-Doctoral Fellowship at The Johns Hopkins University School of Medicine. His educational background supports his expertise in managing safety signals within the oncology clinical portfolio.
Career Background in Clinical Trials
John Yongbo Li has extensive experience in clinical trial management. He worked as a Clinical Trial Manager at Wyeth for 11 months in 2007 and served as a Clinical Trial Leader at Novartis from 2003 to 2005. He also held the position of Pharmacovigilance Lead/Project Manager at Numoda Corporation from 2008 to 2010. His roles have involved overseeing clinical trials and ensuring compliance with safety regulations.
Experience at CSL Behring and Johns Hopkins Hospital
From 2018 to 2022, John Yongbo Li was employed at CSL Behring as a Clinical Safety Physician and Medical Evaluator in Global Clinical Safety & Pharmacovigilance. Prior to that, he completed a six-year fellowship at Johns Hopkins Hospital from 1994 to 2000. His experience in these institutions has contributed to his proficiency in clinical safety and pharmacovigilance.